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Background: Low-intensity pulsed ultrasound is a pain-free therapy performed daily at home by the patient and
has been shown to promote fracture healing. Teriparatide is a parathyroid hormone preparation that activates
osteoblastic bone formation and is also reported to be effective in promoting bony union.
Case presentation: We report the case of a 56-year-old Japanese male with a femoral shaft fracture who underwent
intramedullary osteosynthesis nailing initially. He had no radiologic or clinical sign of healing 3 months later and
low-intensity pulsed ultrasound was initiated at that time. He was reassessed in another 3 months, with evidence
of mild bone consolidation but the fracture gap persisted. Subsequent treatment with human parathyroid hormone
was initiated in combination with low-intensity pulsed ultrasound. Full fracture healing was present 6 months after
beginning the combination low-intensity pulsed ultrasound and teriparatide. It is hypothesized that the potential
additive effects of low-intensity pulsed ultrasound and teriparatide therapy ultimately triggered sufficient bone formation
to support osseous union.
Conclusion: The case reported herein is a femoral shaft atrophic nonunion in which traditional interventions
failed. Successful fracture healing was finally achieved with low-intensity pulsed ultrasound and teriparatide therapy.
This is the first reported case of diaphyseal nonunion with deterioration of bone quality in long bones resolved with
teriparatide and low-intensity pulsed ultrasound.
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The effect of low-intensity pulsed ultrasound (LIPUS) on
the stimulation of bone formation in fracture and in
cases of nonunion has been extensively studied [1].
However, there are cases in which bone union is not ob-
tained even with the use of LIPUS, and it is difficult to
judge the most appropriate timing for repeat surgery. A
large physical, mental and social burden is placed on the
patient when repeat surgery is needed. Teriparatide is a
recombinant human parathyroid hormone [1–34] (PTH)
preparation that is used in the treatment of osteoporosis,
and is also reported to be effective in promoting bony
union [2]. Teriparatide is effective because of its activa-
tion of osteoblastic bone formation [3]. Although both
teriparatide and LIPUS have been found to accelerate* Correspondence: kk-nozaka@mue.biglobe.ne.jp
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unless otherwise stated.fracture-healing processes [4], the effect of the combin-
ation of teriparatide and LIPUS in clinical bone fracture
management is unclear.
Case presentation
A 56-year-old Japanese man was involved in a traffic acci-
dent. He was diagnosed with left diaphyseal femoral shaft
fracture (OTA [Orthopaedic Trauma Association’s Frac-
ture and Dislocation Compendium] 32-C1.3) (Figure 1)
and was treated with intramedullary osteosynthesis nailing
surgery at another hospital (Figure 2). Radiologic assess-
ments at 3 months (Figure 3) did not show any sign of
healing. This was consistent with the clinical manifesta-
tions of pain, movement at the fracture site, and left leg
weakness. Physical examination and laboratory tests, in-
cluding white blood cell counts, C-reactive protein, and
erythrocyte sedimentation rate, were normal (Table 1), rul-
ing out underlying infection. The patient denied smokingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Left, postoperative radiologic image of the femoral
diaphyseal fracture (OTA 1, 32-C1.3) treated using interlocked
intramedullary nailing. Right, magnification of the image above.
Figure 1 Preoperative radiographs. The femoral diaphyseal
fracture (OTA 1, 32-C1.3).
Figure 3 Left, radiologic image at 3 months, showing no signs
of healing but also no displacement. LIPUS was started at this
point. Right, magnification of the image above.
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Figure 4 Left, radiological image at 6 months, showing signs of
nonunion, nondisplaced diaphysis, atrophic bone with gap.
Teriparatide was started at this point. Right, magnification of the
image above.









BAP (μg/ml) (3.7-20.9) 25.4 19.9
PINP (μg/ml) (19.5-71.2) 37.1 48.0
DPD (nmol/mml·Cr) (2.1-5.4) 18.7 6.9
Serum NTX (NMOLBCE/L) (9.5-17.7) 17.6 16.6
TRACP-5B (μU/dl) (170–590) 446 272
ucOC (ng/ml) (<4.5) 18.8 5.6
Serum Hcys (nmol/ml) (3.7-13.5) 21.9 10.9
Urine Pen (μg/mg·Cr) (0.019-0.070) 0.042 0.023
intactPTH (pg/ml) (10–65) 57 54
25-OHVitD (ng/ml) (7–41) 7 10
Vit.B12 (pg/ml) (180–914) 700 981
Vit.B6 (ng/ml) (6–40) 7.2 15.2
Folate (ng/ml) (>3.1) 2.0 4.2
Ca (mg/dL) (8.4-9.7) 8.6 9.1
P (mg/dL) (2.5-4.5) 2.9 2.7
Cr (mg/dL) (0.6-1.2) 0.9 0.9
eGFR (ml/min/1.73 m2) (>90) 98 97
CRP (mg/dL) (<0.3) 0.0 0.0
Abbreviation; BAP Bone alkaline phosphatase, PINP procollagen typeIN-terminal
propeptide, DPD dihydropyrimidine dehydrogenase, NTX N-terminal crosslinking
telopeptide of typeIcollagen, TRACP-5B Tartrate-resistant Acid Phosphatase type
5B, ucOC uncarboxylated osteocalcin, Hcys homocysteine, Pen pentosidine, PTH
parathyroid hormone, 25-OHVitD 25-hydroxyvitamin-D, Ca calcium, P phosphorus,
Cr creatinine, CRP C-reactive protein, eGFR estimated glomerular filtration rate.
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or glucocorticoid intake. Other laboratory data, including
serum alkaline phosphatase, intact PTH, and calcium,
were normal (Table 1). However, he had high levels of
bone quality marker, uncarboxylated osteocalcin ((ucOC),
18.8 ng/ml; reference value, <4.50 ng/ml) and serum
homocysteine ((Hcys), 21.9 nmol/ml; reference value,
3.7 – 13.5 nmol/ml). Dual-energy X-ray absorptiometry
assessment of bone density showed almost normal:
0.891 g/cm2 and T-score of −0.2 standard deviation on his
radius. In other words, this patient had mildly compro-
mised bone quality [5-8]. Callus formation in the fracture
area remained poor 3 months after the first surgery, but
the patient could not take any more time away from his
company. Therefore, when he left the hospital he used
crutches to assist with partial weight bearing ambulation.
Both LIPUS and vitamin K2 preparation administrations
were initiated at this time with the aim of lowering his
high ucOC level. Callus formation in the fracture area was
still insufficient at 3 months following initiation of LIPUS.
Therefore, teriparatide was started in combination with
LIPUS (Figure 4). Callus formation was good when
assessed at 3 months after the start of teriparatide inter-
vention (Figure 5). Bony union was good and full weightbearing was permitted after administration of teriparatide
for 6 months (Figure 6). The ucOC levels improved to
5.6 ng/ml and serum Hcys improved to 10.8 nmol/ml
6 months after initiating teriparatide (Table 1).
Conclusions
Intermittent administration of human parathyroid hor-
mone (hPTH) has an anabolic effect on bone in humans
and is expected to be a potent agent for fracture healing
[3]. For nonunion, a second intervention will undoubt-
edly be necessary, carrying additional risks and potential
complications as well as increases in healthcare costs.
Therefore, any effective treatment that can solve this
situation should be considered. Several recent studies
have revealed that intermittent treatment with PTH
stimulates osteogenesis in experimental fracture healing
of cortical bones and that PTH effects on cortical bone
repair are site-specific. Aspenberg et al., in a prospective,
randomized, double blind study of conservative fracture
treatment for 102 postmenopausal women with distal ra-
dial fractures, showed than the time to healing was
shorter in a teriparatide 20 mg group than in a placebo
Figure 5 Left, image obtained after 3 months of treatment with
teriparatide. Bone bridging and a decrease in interfragment gaps
are observed. Right, magnification of the image above.
Figure 6 Left, image obtained at 6 months showing healing of
the nonunion. Right, magnification of the image above.
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and LIPUS have contrasting additive, rather than syner-
gistic, effects during fracture healing. Teriparatide pri-
marily increased callus bone mineral content (BMC)
without influencing its size, whereas LIPUS increased
callus size without influencing BMC in rat studies. Frac-
ture healing is a complex biologic process and is im-
pacted by multiple factors [10]. Watanabe et al. [11]
reported that LIPUS is a relatively new technique
for the acceleration of fracture healing in nonunion
situations. It has a frequency of 1.5 MHz, a signal burst
width of 200 microseconds, a signal repetition fre-
quency of 1 kHz, and an intensity of 30 mW/cm2. The
beneficial effect of fracture healing acceleration with
LIPUS is considered to be larger in patients with poten-
tially negative factors for fracture healing. LIPUS is a
pain-free therapy performed daily at home by the patient
with the possibility of avoiding further surgical proce-
dures. This outpatient treatment reduces the length of
hospital stays and reduces overall system wide health care
expenses. The incidence of delayed union and nonunion
is 5% to 10% of all fractures. While LIPUS has benefi-
cial effects on collagen enzymatic cross-link formation,
mechanical stress may improve bone quality. Nonunionis a severe complication for the patient, which has a nega-
tive impact on quality of life. Treatment for nonunion typ-
ically requires a second surgical intervention to provide
stability and to stimulate bone healing. These surgeries in-
clude locked intramedullary nailing, dynamic compression
plating, external fixation with Ilizarov’s principles, and at
times autografting. But Brinker et al. reported that all pa-
tients with nonunion who met their screening criteria
should be referred to an endocrinologist for evaluation be-
cause they were likely to have undiagnosed metabolic or
endocrine abnormalities that would interfere with bone
healing [12]. Two interventions found to accelerate frac-
ture healing processes are conbination of LIPUS and teri-
paratide without a second surgical intervention in this
nonunion patient with deteriorated bone quality. No side
effects occurred.
The case reported herein is a femoral shaft atrophic
nonunion in which traditional interventions failed. This
is the first reported case of diaphyseal nonunion with
deterioration of bone quality in long bones resolved with
teriparatide and LIPUS. The difference in teriparatide ac-
tivity on trabecular and cortical bone suggests that teri-
paratide could accelerate healing in nonunions in
diaphyseal nonunion in long bone with deterioration of
bone quality. The authors are aware that this is just one
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trials with larger groups of subjects must be conducted
in order to assess the efficacy of combination teripara-
tide and LIPUS intervention and the fracture healing.Consent
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